🔗 Share this article

Treasury head Reeves has announced she is planning "specific action to tackle cost of living issues" in next month's Budget.

In comments to the BBC, she stated that reducing inflation is a shared responsibility of both the government and the central bank.

The UK's inflation rate is projected to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Potential Utility Bill Interventions

It is understood the administration could intervene to lower utility costs, for example by cutting the current 5% level of VAT charged on energy.

Another possibility is to cut some of the regulatory levies currently included in bills.

Fiscal Limitations and Analyst Predictions

The administration will receive the next draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for these actions.

The consensus from most experts is that the Chancellor will have to declare tax rises or spending cuts in order to meet her declared fiscal targets.

Previously on Thursday, estimates showed there was a £22bn deficit for the Treasury chief to fill, which is at the lower end of forecasts.

"It is a joint task between the Bank of England and the administration to continue tackling some of the causes of inflation," Reeves informed the BBC in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Commitments and International Issues

While much of the attention has been on probable tax increases, the chancellor said the latest data from the fiscal watchdog had not altered her commitment to election pledges not to raise tax levels on earnings tax, sales tax or social security contributions.

She blamed an "uncertain world" with growing international and trade concerns for the fiscal revenue measures, likely to be targeted on those "with the broadest shoulders."

International Trade Disputes

Referring to concerns about the UK's trade ties with the Asian nation she said: "The UK's national security always come first."

Recent declaration by Chinese authorities to tighten trade restrictions on rare earths and other resources that are crucial for advanced tech production led US President the US President to propose an further 100% tariff on imports from the Asian country, increasing the risk of an full-scale trade war between the two largest economies.

The US Treasury Secretary called the Chinese move "commercial pressure" and "a global supply chain control attempt."

Asked about considering the US offer to participate in its dispute with China, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "bad for the world economy and generates further obstacles."

"It is my opinion there are areas where we should challenge China, but there are also valuable prospects to trade with Chinese markets, including financial services and other areas of the economic system. We've got to achieve that balance appropriate."

The Treasury chief also confirmed she was collaborating with other major economies "on our own critical minerals strategy, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

Reeves also acknowledged that the price the National Health Service pays for pharmaceuticals could go up as a result of current negotiations with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.

A number of the biggest global drug companies have said in recent statements that they are either halting or canceling projects in the UK, with several attributing the modest returns they are getting.

Recently, the government science advisor said the price the NHS pays for drugs would have to increase to prevent companies and drug research funding departing from the United Kingdom.

Reeves stated to media: "We have seen as a result of the pricing regime, that clinical trials, recent pharmaceuticals have not been available in the UK in the extent that they are in other continental states."

"We want to make sure that patients getting care from the NHS are can obtain the finest life-saving medicines in the globe. And so we are looking at these issues, and... seeking to secure increased capital into the UK."